X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs SUVEN LIFE - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA SUVEN LIFE SANOFI INDIA/
SUVEN LIFE
 
P/E (TTM) x 34.4 15.9 215.5% View Chart
P/BV x 6.9 3.8 182.2% View Chart
Dividend Yield % 1.3 0.5 282.7%  

Financials

 SANOFI INDIA   SUVEN LIFE
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
SUVEN LIFE
Mar-17
SANOFI INDIA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs4,560229 1,995.6%   
Low Rs4,400151 2,912.0%   
Sales per share (Unadj.) Rs1,028.542.7 2,408.4%  
Earnings per share (Unadj.) Rs129.06.9 1,882.7%  
Cash flow per share (Unadj.) Rs186.08.5 2,179.7%  
Dividends per share (Unadj.) Rs68.001.00 6,800.0%  
Dividend yield (eoy) %1.50.5 288.1%  
Book value per share (Unadj.) Rs753.652.4 1,438.1%  
Shares outstanding (eoy) m23.03127.28 18.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.4 98.0%   
Avg P/E ratio x34.727.7 125.4%  
P/CF ratio (eoy) x24.122.2 108.3%  
Price / Book Value ratio x5.93.6 164.1%  
Dividend payout %52.714.6 361.2%   
Avg Mkt Cap Rs m103,17424,158 427.1%   
No. of employees `0003.61.0 356.6%   
Total wages/salary Rs m3,592522 688.5%   
Avg. sales/employee Rs Th6,537.75,349.7 122.2%   
Avg. wages/employee Rs Th991.4513.5 193.1%   
Avg. net profit/employee Rs Th819.8858.1 95.5%   
INCOME DATA
Net Sales Rs m23,6865,435 435.8%  
Other income Rs m708211 335.7%   
Total revenues Rs m24,3945,646 432.0%   
Gross profit Rs m5,2811,291 409.2%  
Depreciation Rs m1,313214 613.3%   
Interest Rs m1557 26.4%   
Profit before tax Rs m4,6611,231 378.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691359 471.3%   
Profit after tax Rs m2,970872 340.6%  
Gross profit margin %22.323.7 93.9%  
Effective tax rate %36.329.2 124.4%   
Net profit margin %12.516.0 78.2%  
BALANCE SHEET DATA
Current assets Rs m15,6734,917 318.7%   
Current liabilities Rs m6,6781,186 563.0%   
Net working cap to sales %38.068.6 55.3%  
Current ratio x2.34.1 56.6%  
Inventory Days Days7662 122.3%  
Debtors Days Days2231 72.5%  
Net fixed assets Rs m8,0983,154 256.7%   
Share capital Rs m230127 180.9%   
"Free" reserves Rs m17,0886,543 261.2%   
Net worth Rs m17,3566,670 260.2%   
Long term debt Rs m0259 0.0%   
Total assets Rs m25,4008,157 311.4%  
Interest coverage x311.722.7 1,375.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.7 139.9%   
Return on assets %11.811.4 103.2%  
Return on equity %17.113.1 130.9%  
Return on capital %26.918.6 145.0%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,1454,996 143.0%   
Fx outflow Rs m6,846959 713.9%   
Net fx Rs m2994,037 7.4%   
CASH FLOW
From Operations Rs m3,2261,088 296.4%  
From Investments Rs m-1,555-3,107 50.1%  
From Financial Activity Rs m-1,818-300 605.6%  
Net Cashflow Rs m-147-2,319 6.3%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.0 -  
FIIs % 14.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 36.5 28.8%  
Shareholders   15,184 37,287 40.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  NATCO PHARMA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 21, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - DR. REDDYS LAB COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS